Observational Study of AID Systems in Pregnant Individuals with Type 1 Diabetes

This observational study aims to understand how automated insulin delivery (AID) systems affect pregnant individuals with type 1 diabetes (T1D) and their babies. Researchers will compare those using commercially available AID systems with those using open-source AID systems. The study will look at outcomes like whether babies are born large for gestational age (LGA), the emotional impact of T1D (measured by the Type 1 Diabetes Distress Assessment Scale or T1-DDAS), and high blood pressure during pregnancy (hypertensive disorders of pregnancy or HDP). You may be able to join if you are pregnant, have T1D diagnosed before pregnancy, and are currently using an AID system. The study plans to enroll 1000 participants.

Study design
This is an observational study, meaning researchers will watch and collect information without giving specific treatments. It plans to include 1000 pregnant individuals.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed from enrollment until 8 weeks after giving birth for some outcomes, and until delivery for others.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06654713

Commercial or Open Source Closed Loop Impact on Pregnancy Study

Recruiting
Not specifiedAges 18+Observational
University of California, San Francisco
~1,000 participants
Updated 2026-07-27 on ClinicalTrials.gov
What's tested:Commercial AID systemOpen source AID system

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Large for gestational age (LGA)
Measured over At delivery
+3 more outcomes measured
Type 1 Diabetes
Pregnancy, High Risk
Insulin Dependent Diabetes
Pregnancy Related
1 sites across 1 states
California1
  • Nasim Sobhani, MD · PRINCIPAL_INVESTIGATOR · University of California, San Francisco

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Pregnant
Diagnosis of type 1 diabetes (T1D) prior to pregnancy
Active use of automated insulin delivery (AID) system

Exclusion

Diagnosis of other forms of diabetes (gestational diabetes, type 2 diabetes, monogenic diabetes)
  • Large for gestational age (LGA)At delivery

    Primary neonatal outcome. LGA defined as birth weight \> 90th percentile for gestational age

  • Core score on Type 1 Diabetes Distress Assessment Scale (T1-DDAS)From enrollment to 8 weeks postpartum

    Primary behavioral outcome. Score ranges from 1-5. Higher scores indicate higher degrees of diabetes distress.

  • Hypertensive disorders of pregnancy (HDP)From enrollment to 8 weeks postpartum.

    Primary maternal outcome. As defined by the American College of Obstetricians and Gynecologists (ACOG).

  • Time in pregnancy-specific range (psTIR)From enrollment to 8 weeks postpartum.

    Primary glycemic outcome. Defined as percent of time spent with sensor glucose in pregnancy range of 63-140 mg/dL.